期刊文献+

Oncologic safety of colonic stenting as a bridge to surgery in leftsided malignant colonic obstruction:Current evidence and prospects 被引量:1

下载PDF
导出
摘要 Approximately 7%-29%of patients with colorectal cancer present with colonic obstruction.The concept of self-expandable metal stent(SEMS)insertion as a bridge to surgery(BTS)is appealing.However,concerns on colonic stenting possibly impairing oncologic outcomes have been raised.This study aimed to review current evidence on the short-and long-term oncologic outcomes of SEMS insertion as BTS for left-sided malignant colonic obstruction.For short-term outcomes,colonic stenting facilitates a laparoscopic approach,increases the likelihood of primary anastomosis without a stoma,and may decrease postoperative morbidity.However,SEMS-related perforation also increases local recurrence and impairs overall survival.Moreover,colonic stenting may cause negative oncologic outcomes even without perforation.SEMS can induce shear forces on the tumor,leading to increased circulating cancer cells and aggressive pathological characteristics,including perineural and lymphovascular invasion.The conflicting evidence has led to discordant guidelines.Well-designed collaborative studies that integrate both oncologic outcomes and data on basic research(e.g.,alteration of circulating tumors)are needed to clarify the actual benefit of colonic stenting as BTS.
出处 《World Journal of Clinical Oncology》 CAS 2022年第12期943-956,共14页 世界临床肿瘤学杂志(英文版)
  • 相关文献

参考文献4

二级参考文献191

  • 1Alvaro Arjona-Sánchez,Francisco Javier Medina-Fernández,Francisco Cristobal Mu?oz-Casares,Angela Casado-Adam,Juan Manuel Sánchez-Hidalgo,Sebastián Rufián-Pe?a.Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview[J].World Journal of Gastrointestinal Oncology,2014,6(10):407-412. 被引量:8
  • 2Cunningham D,Allum WH,Stenning SP,菅鑫妍.手术期间化学疗法与单独手术治疗可切除的胃食管癌疗效比较[J].中国处方药,2006,5(8):59-60. 被引量:434
  • 3Douglas Hanahan,Robert A. Weinberg.Hallmarks of Cancer: The Next Generation[J]. Cell . 2011 (5)
  • 4Semenza G L.Targeting HIF-1 for Cancer Therapy. Nature Reviews Cancer . 2003
  • 5Anke M. J. Kuijpers,Boj Mirck,Arend G. J. Aalbers,Simon W. Nienhuijs,Ignace H. J. T. Hingh,Martinus J. Wiezer,Bert Ramshorst,Robert J. Ginkel,Klaas Havenga,Andreas J. Bremers,Johannes H. W. Wilt,Elisabeth A. Velde,Vic J. Verwaal.Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol[J]. Annals of Surgical Oncology . 2013 (13)
  • 6G. Passot,N. Bakrin,A.S. Roux,D. Vaudoyer,F.-N. Gilly,O. Glehen,E. Cotte.Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients[J]. European Journal of Surgical Oncology . 2013
  • 7Manuel J. Koppe,Otto C. Boerman,Wim J. G. Oyen,Robert P. Bleichrodt.Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies[J]. Annals of Surgery . 2006 (2)
  • 8Verwaal VJ,van Ruth S,de Bree E,et al.Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology . 2003
  • 9Astrid E. Greijer,Pien M. Delis-van Diemen,Remond J. A. Fijneman,Rachel H. Giles,Emile E. Voest,Victor W. M. Hinsbergh,Gerrit A. Meijer.Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum[J]. Virchows Archiv . 2008 (5)
  • 10Hiroaki Kataoka,Hiroyuki Tanaka,Koki Nagaike,Shuichiro Uchkama,Hiroshi Itoh.Role of cancer cell-stroma interaction in invasive growth of cancer cells[J]. Human Cell . 2003 (1)

共引文献66

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部